Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Addition of related topic links 'Multiple myeloma' and 'MedlinePlus Genetics' on the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-26T20:24:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now consolidates site locations under a single 'Locations' section, removing the previous per-state location subsections (e.g., 'Alabama Locations', 'California Locations', etc.). The 'HHS Vulnerability Disclosure' section has been removed.
    Difference
    1%
    Check dated 2025-12-19T13:57:24.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page no longer lists 'Multiple myeloma' as a topic and removes related topics including MedlinePlus Genetics. This reduces explicit disease labeling and related topic references on the study page.
    Difference
    0.1%
    Check dated 2025-12-12T07:22:43.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears to be a minor backend update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T02:17:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added note that the Publications section is auto-filled from PubMed and may not reflect the study content, and updated the revision tag to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:12:51.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    A government funding/operating status notice has been removed from the page, a non-substantive content update that does not affect study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T15:34:29.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.